Physician profile
Neven Kosic
NPI 1831162841
$12,015.68
in general payments reported to CMS, 2019-2025
42 companies · $2,053 in 2025
The $2,053 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $393 · 2021: $1,864 · 2022: $2,487 · 2023: $2,443 · 2024: $2,550 · 2025: $2,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,510 · Education: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,509.69 |
| Education | $535.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,762.64 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,534.46 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.39 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $606.10 | 2019-2025 | Xywav |
| Regeneron Healthcare Solutions, INC. | $531.41 | 2022-2025 | Dupixent |
| Genzyme Corporation | $476.66 | 2020-2025 | |
| Actelion Pharmaceuticals US, INC. | $459.76 | 2021-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $445.00 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $337.90 | 2020-2024 | |
| Amgen INC. | $315.63 | 2022-2025 | Tezspire |
| Inspire Medical Systems, INC. | $312.52 | 2023-2025 | Inspire |
| Mallinckrodt Hospital Products INC. | $253.54 | 2021-2023 | Acthar |
| Genentech USA, INC. | $250.05 | 2019-2021 | |
| Harmony Biosciences LLC | $238.56 | 2023-2025 | Wakix |
| Boston Scientific Corporation | $181.27 | 2022-2023 | Watchman Access System, Rezum Generator |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $178.22 | 2021-2025 | Prolastin-C Liquid |
| Electromed, INC. | $140.74 | 2021-2024 | Smartvest |
| Baxter Healthcare | $113.39 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Avadel Cns Pharmaceuticals, LLC | $113.33 | 2023-2025 | Lumryz |
| Sanofi-Aventis U.S. LLC | $97.99 | 2025 | |
| Janssen Pharmaceuticals, INC | $70.34 | 2021 | |
| Philips North America LLC | $70.10 | 2020-2025 | Vest Therapy Und |
| Vapotherm INC | $65.30 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $63.73 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $59.09 | 2021 | |
| Insmed, INC. | $54.69 | 2021-2025 | Arikayce |
| Advanced Respiratory, INC | $44.94 | 2020 | |
| Pulmonx Corporation | $44.81 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Verona Pharma, INC. | $39.23 | 2025 | Ohtuvayre |
| Tactile Systems Technology INC | $32.38 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Alexion Pharmaceuticals, INC. | $30.79 | 2021 | |
| Csl Behring | $27.30 | 2020 | |
| Lilly USA, LLC | $21.99 | 2025 | Zepbound |
| Itamar Medical INC | $20.45 | 2022 | |
| Resmed Corp | $18.91 | 2019 | |
| Pfizer INC. | $17.95 | 2023 | |
| Vifor Pharma, INC. | $17.88 | 2025 | Zemaira |
| Gilead Sciences, INC. | $17.64 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.19 | 2025 | Alvesco |
| Zoll Respicardia, INC. | $15.85 | 2024 | Remede System |
| Liquidia Technologies, INC. | $13.56 | 2025 | Yutrepia |
| Paratek Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neven Kosic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.